Related Experiment Videos
Hyperlipidemia as a risk factor of renal allograft function impairment
1Department of Internal Medicine, Botucatu Medical School, UNESP, Brazil. vsoares@laser.com.br
Insights
Hypertriglyceridemia, not hypercholesterolemia, is linked to kidney transplant graft dysfunction. This study found higher triglyceride levels negatively impacted graft function over time, unlike high cholesterol levels.
Area of Science:
- Nephrology
- Transplantation Immunology
- Cardiovascular Medicine
Background:
- Hyperlipidemia is a common comorbidity in renal allograft recipients.
- The differential impact of hypercholesterolemia and hypertriglyceridemia on kidney transplant outcomes remains unclear.
Purpose of the Study:
- To prospectively compare graft outcomes in renal allograft recipients with and without hypercholesterolemia and hypertriglyceridemia.
Main Methods:
- Prospective comparison of graft outcomes in renal transplant recipients categorized into high cholesterol (HCG) vs. normal cholesterol (NCG) groups, and high triglyceride (HTG) vs. normal triglyceride (NTG) groups.
- Assessment of various clinical parameters including age, hypertension, donor type, immunosuppression, rejection episodes, diabetes, proteinuria, and serum creatinine levels.
- Evaluation of the probability of serum creatinine doubling and actuarial graft survival over extended follow-up periods.
Main Results:
- No significant differences were observed between cholesterol groups (NCG vs. HCG) or triglyceride groups (NTG vs. HTG) in baseline characteristics or graft survival.
- Hypertriglyceridemia was significantly associated with an increased probability of serum creatinine doubling over time (12-120 months) compared to normal triglyceride levels.
- Hypercholesterolemia did not show a statistically significant association with the probability of serum creatinine doubling.
Conclusions:
- Hypertriglyceridemia, but not hypercholesterolemia, is independently associated with a loss of graft function in renal allograft recipients.
- Monitoring and management of triglyceride levels may be crucial for preserving kidney allograft function.
Abstract:
In this study, the graft outcome in renal allograft recipients with [high cholesterol group (HCG), n = 30] or without [normal cholesterol group (NCG), n = 42] hypercholesterolemia and with [high triglyceride group (HTG), n = 33] or without [normal triglyceride group (NTG), n = 36] hypertriglyceridemia were prospectively compared. At 6 months post-transplantation, no significant difference was observed between the groups (NTG compared with HTG, and NCG compared with HCG) regarding age, presence of arterial hypertension, kind of donor (living related or cadaveric), immunosuppressive therapy, number of rejection episodes per patient, frequency of patients with acute cellular rejection, prevalence of patients with diabetes mellitus or proteinuria > 3 g/24 h, and mean serum creatinine. The probability of doubling serum creatinine during follow-up was statistically different between NTG and HTG (12 months: NTG = 0.03, HTG = 0.15; 36 months: NTG = 0.08, HTG = 0.33: 60 months: NTG = 0.08, HTG = 0.48; and 120 months: NTG = 0.18, HTG = 0.48), but not between NCG and HCG (12 months: NCG = 0.05, HCG = 0.13; 36 months: NCG = 0.13, HCG = 0.24; 60 months: NCG = 0.19, HCG = 0.31; 84 months: NCG = 0.27, HCG = 0.31). There was no significant difference in actuarial graft survival between HCG and NCG or between NTG and HTG. Hypertriglyceridemia, but not hypercholesterolemia, was associated with loss of graft function.